Quidel Q2 Revenues up 12 Percent; Discloses New Life Tech Deal for PCR Assays | GenomeWeb

NEW YORK (GenomeWeb News) – Quidel reported after the close of the market on Wednesday that second-quarter revenues rose 12 percent year over year.

The San Diego diagnostics firm beat the consensus Wall Street estimate by posting revenues of $30.9 million for the three months ended June 30, compared to $27.5 million a year ago. Analyst estimates called for an average of $30.3 million in revenues.

R&D costs increased to $6.8 million, up 10 percent from $6.2 million a year ago, and SG&A spending was up 6 percent to $12.8 million from $12.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.